BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Limosilactobacillus fermentum {L. fermentum} - Salmonella enterica subsp. enterica serovar Typhimurium str. ST4/74 |
👶
Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin. BMC microbiology (BMC Microbiol ) Vol: 8 Issue Pages: 132 Pub: 2008 Aug 4 Epub: 2008 Aug 4 Authors Truusalu K , Mikelsaar RH , Naaber P , Karki T , Kullisaar T , Zilmer M , Mikelsaar M , Html Article Publication |
| Limosilactobacillus fermentum {L. fermentum} - Salmonella enterica subsp. enterica serovar Typhimurium str. ST4/74 |
👶
Immunological, antioxidative, and morphological response in combined treatment of ofloxacin and Lactobacillus fermentum ME-3 probiotic in Salmonella Typhimurium murine model. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica (APMIS ) Vol: 118 Issue 11 Pages: 864-72 Pub: 2010 Nov Epub: 2010 Sep 14 Authors Truusalu K , Kullisaar T , Hütt P , Mahlapuu R , Aunapuu M , Arend A , Zilmer M , Mikelsaar RH , Mikelsaar M , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
